Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy (2022) Tawk B, Wirkner U, Schwager C, Rein K, Zaoui K, Federspil PA, Adeberg S, et al. Journal article A disease network-based deep learning approach for characterizing melanoma (2021) Lai X, Zhou J, Wessely A, Heppt M, Maier A, Berking C, Vera J, Zhang L Journal article, Original article Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis (2021) Buergy D, Wuerschmidt F, Gkika E, Hoerner-Rieber J, Knippen S, Gerum S, Balermpas P, et al. Journal article BiasCorrector: Fast and accurate correction of all types of experimental biases in quantitative DNA methylation data derived by different technologies (2021) Kapsner L, Zavgorodnij MG, Majorova SP, Hotz-Wagenblatt A, Kolychev OV, Lebedev IN, Hoheisel JD, et al. Journal article Association of genomic variants at PAX8 and PBX2 with cervical cancer risk (2021) Ramachandran D, Wang Y, Schuermann P, Huelse F, Mao Q, Jentschke M, Boehmer G, et al. Journal article Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial (2020) Staehler M, Stoeckle M, Christoph DC, Stenzl A, Potthoff K, Grimm MO, Klein D, et al. Journal article Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk,HPVstatus and gene expression levels (2020) Ramachandran D, Schuermann P, Mao Q, Wang Y, Bretschneider LM, Speith LM, Huelse F, et al. Journal article Breast cancer risk in BRCA1/2 mutation carriers and noncarriers under prospective intensified surveillance (2020) Engel C, Fischer C, Zachariae S, Bucksch K, Rhiem K, Giesecke J, Herold N, et al. Journal article Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma (2020) Brill R, Uller W, Huf V, Müller-Wille R, Schmid I, Pohl A, Häberle B, et al. Journal article First-line pazopanib in intermediate- and poor-risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial (2020) Staehler M, Panic A, Goebell P, Merling M, Potthoff K, Herrmann E, de Geeter P, et al. Journal article